Cargando…

Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX Trial

Background Among medically ill patients treated with thromboprophylaxis, betrixaban was not associated with an increase in major bleeding compared with enoxaparin, but an increase in clinically relevant non-major (CRNM) bleeding was observed. The aim of this analysis is to describe the severity and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yee, Megan K., Gibson, C. Michael, Nafee, Tarek, Kerneis, Mathieu, Daaboul, Yazan, Korjian, Serge, Chi, Gerald, AlKhalfan, Fahad, Hernandez, Adrian F., Hull, Russell D., Cohen, Alexander T., Goldhaber, Samuel Z.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2019
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524922/ https://www.ncbi.nlm.nih.gov/pubmed/31249989 http://dx.doi.org/10.1055/s-0039-1685496

Ejemplares similares

Association of D-dimer Levels with Clinical Event Rates and the Efficacy of Betrixaban versus Enoxaparin in the APEX Trial
por: Gibson, C. Michael, et al.
Publicado: (2018)

Machine learning to predict venous thrombosis in acutely ill medical patients
por: Nafee, Tarek, et al.
Publicado: (2020)

Comparison of Fatal or Irreversible Events With Extended‐Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely Ill Medical Patients: An APEX Trial Substudy
por: Gibson, C. Michael, et al.
Publicado: (2017)

Pheochromocytoma Presenting as Partial HELLP Syndrome
por: Daaboul, Yazan, et al.
Publicado: (2015)

Safety and Efficacy of Rivaroxaban When Added to Aspirin Monotherapy Among Stabilized Post‐Acute Coronary Syndrome Patients: A Pooled Analysis Study of ATLAS ACS‐TIMI 46 and ATLAS ACS 2‐TIMI 51
por: Gibson, William J., et al.
Publicado: (2019)

The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification
por: Gibson, C. Michael, et al.
Publicado: (2017)

Pectoralis Major Rupture: A Case Report
por: Qylafi, Kristo, et al.
Publicado: (2022)

Risk factors for major bleeding in the SEATTLE II trial
por: Sadiq, Immad, et al.
Publicado: (2017)

d-Dimer elevation and adverse outcomes
por: Halaby, Rim, et al.
Publicado: (2014)

Medical education in a foreign language and history-taking in the native language in Lebanon – a nationwide survey
por: Abi Raad, Vanda, et al.
Publicado: (2016)

External validation of the ADA score for predicting thrombosis among acutely ill hospitalized medical patients from the APEX Trial
por: Chi, Gerald, et al.
Publicado: (2022)

Estimation of Acutely Ill Medical Patients at Venous Thromboembolism Risk Eligible for Extended Thromboprophylaxis Using APEX Criteria in US Hospitals
por: Martin, Anne-Céline, et al.
Publicado: (2019)

Enoxaparin-sodium/fondaparinux-sodium: Major and clinically relevant bleeding complications: 8 case reports
Publicado: (2020)

Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy
por: Gibson, C. Michael, et al.
Publicado: (2017)

Comparison of bleeding risk scores and evaluation of major bleeding predictive factors in patients with major bleeding due to vitamin K antagonist use
por: Yildirim, Sinan, et al.
Publicado: (2023)

Biological basis and proposed mechanism of action of CSL112 (apolipoprotein A-I [human]) for prevention of major adverse cardiovascular events in patients with myocardial infarction
por: Korjian, Serge, et al.
Publicado: (2023)

Warfarin: Major bleeding complication manifesting as retroperitoneal bleed: case report
Publicado: (2020)

Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I)
por: Michael Gibson, C., et al.
Publicado: (2016)

Major gastrointestinal bleeding and antithrombotics: Characteristics and management
por: Bouget, Jacques, et al.
Publicado: (2020)

Heparin: Major bleeding event: case report
Publicado: (2021)

Major Bleeding Complications in COVID-19 Patients
por: Boira, Ignacio, et al.
Publicado: (2021)

Etiology of End-Stage Renal Disease and Arterial Stiffness among Hemodialysis Patients
por: El Ghoul, Balsam, et al.
Publicado: (2017)

Therapeutic Strategies Following Major, Clinically Relevant Nonmajor, and Nuisance Bleeding in Atrial Fibrillation: Findings From ORBIT‐AF
por: O'Brien, Emily C., et al.
Publicado: (2018)

The AngelMed Guardian(®) System in the Detection of Coronary Artery Occlusion: Current Perspectives
por: Kazmi, Syed Hassan Abbas, et al.
Publicado: (2020)

Antiplatelets/enoxaparin-sodium: Major bleeding: case report
Publicado: (2020)

Mild phenotype of knockouts of the major apurinic/apyrimidinic endonuclease APEX1 in a non-cancer human cell line
por: Kim, Daria V., et al.
Publicado: (2021)

Management of bleeding following major trauma: a European guideline
por: Spahn, Donat R, et al.
Publicado: (2007)

Management of bleeding following major trauma: an updated European guideline
por: Rossaint, Rolf, et al.
Publicado: (2010)

Anticoagulation Reversal and Treatment Strategies in Major Bleeding: Update 2016
por: Christos, Steve, et al.
Publicado: (2016)

High incidence of major bleeding with off-label use of edoxaban
por: Fukui, Rika, et al.
Publicado: (2021)

Association Between Diabetes and Major Bleeding Complications of Renal Biopsy
por: Hasegawa, Sho, et al.
Publicado: (2021)

Risk factors for major gastrointestinal bleeding in the general population in Finland
por: Vora, Pareen, et al.
Publicado: (2022)

Prediction of major bleeding events in 1381 patients with essential thrombocythemia
por: Stuckey, Ruth, et al.
Publicado: (2023)

Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban
por: Kirchhof, Paulus, et al.
Publicado: (2020)

Prediction of Major Bleeding in Anticoagulated Patients for Venous Thromboembolism: Comparison of the RIETE and the VTE-BLEED Scores
por: Lecumberri, Ramón, et al.
Publicado: (2021)

Available Bleeding Scoring Systems Poorly Predict Major Bleeding in the Acute Phase of Pulmonary Embolism
por: Mathonier, Camille, et al.
Publicado: (2021)

Genetic Factors of Renin–Angiotensin System Associated with Major Bleeding for Patients Treated with Direct Oral Anticoagulants
por: Yee, Jeong, et al.
Publicado: (2022)

Comparison Between the Accuracy of NovApex Apex Locator and Radiographs in Determining Radiographic Apex
por: Shahi, Shahriar, et al.
Publicado: (2011)

CXCR7 Targeting and Its Major Disease Relevance
por: Wang, Chuan, et al.
Publicado: (2018)

Gestational Diabetes – Major New Clinically Relevant Aspects
por: Schäfer-Graf, Ute Margaretha
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vl1899rn0ote920m3v1oo9jji6